Target intelligence / Profile preview

Selenoprotein K pseudogene 3 (SELENOKP3)

Target
SELENOKP3
Molecular classification
Other (pseudogene)
01

Overview

SELENOKP3, or Selenoprotein K pseudogene 3, is classified as a pseudogene—a non-functional genomic segment related to the functional Selenoprotein K (SELENOK) gene[4]. As a pseudogene, SELENOKP3 does not code for a functional protein and has no established biological activity or disease associations. Pseudogenes result from gene duplication or retrotransposition events followed by mutational inactivation, often lacking transcription or protein-coding capability; occasionally, some pseudogenes may exert regulatory effects at the RNA level, like acting as competing endogenous RNAs, but these functions have not been specifically documented for SELENOKP3[2]. SELENOKP3 is not considered a therapeutic target, receptor, enzyme, or transporter[4]. SELENOKP3 is not the same as SELENOK (Selenoprotein K), which is a protein-coding gene involved in immune cell calcium signaling and ER-associated protein degradation[1]. Pseudogenes, like SELENOKP3, are usually regarded as non-functional remnants of evolution, though some may gain regulatory functions in rare cases[2]. There are no drugs, mechanisms of drug action, biomarkers, or therapeutic safety concerns associated with SELENOKP3. This entry is likely to be of limited utility in drug discovery or biomedical research focused on therapeutic targets.

Other names
SELENOK Pseudogene 3
02

Biological functions

Other (no direct protein product or function; possible regulatory RNA functions are possible for some pseudogenes in general, but none are specifically established for SELENOKP3)
03

Disease associations

Other (no diseases directly associated with SELENOKP3)

Beyond the preview

Go deeper on Selenoprotein K pseudogene 3 (SELENOKP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Selenoprotein K pseudogene 3 (SELENOKP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call